---

6 May 2009 : Column 202W—continued

Dietary Supplements: EU Law

Mike Penning: To ask the Secretary of State for Health what assessment the Food Standards Agency has made of the likely effects on manufacturers and retailers of nutritional supplements of the provisions of Article (a) 13.3 and (b) 16.1, 17.1 and 18.4 of the EU Nutrition and Health Claims Regulation in relation to the role of the European Food Safety Authority. [272376]

Dawn Primarolo: The regulation has transition periods to allow food business operators to respond to the effect of decisions on the authorisation of health claims, such as the need to re-label if claims are not authorised. Any delays in completing the process set out in the provisions to these articles could affect the ability of food business operators to respond to new conditions on products within normal re-labelling cycles and additional costs could occur. This possible outcome was discussed in the impact assessment the Food Standards Agency finalised in July 2007.

Mike Penning: To ask the Secretary of State for Health what recent representations he has received from manufacturers and retailers of nutritional supplements on the economic impact assessment of the EU Nutrition and Health Claims Regulation. [272407]

Dawn Primarolo: My right hon. Friend the Secretary of State for Health has not received any such representations. Written representations with revised assessments of the economic impact of the European Union Nutrition and Health Claims Regulation have however been received by Food Standards Agency officials from two of the food supplement industry's trade associations.

Mike Penning: To ask the Secretary of State for Health what information his Department holds on applications to the European Food Safety Authority for the approval of statements submitted under Article 13.1 of the EU Nutrition and Health Claims Regulation. [272408]

Dawn Primarolo: The Food Standards Agency (FSA) has kept a record of all claims submitted to the United Kingdom under Article 13.1 of the Nutrition and Health Claims Regulation for application to the European Union list, and subsequent correspondence with submitters. Details of the consolidated EU list of health claims undergoing assessment, which also includes applications submitted by other member states, is publicly available on the European Food Safety Authority's website. The FSA has kept stakeholders fully informed of developments with the Article 13 process and will continue to do so as work progresses.

Drugs: Babies

Norman Lamb: To ask the Secretary of State for Health how many children were drug dependent at birth in each region in each of the last five years; and what the numbers of such children in the case of each type of drug were. [Official Report, 1 June 2009, Vol. 493, c. 1MC.] [271664]

Dawn Primarolo: The following tables show the number of finished consultant episodes (FCEs) where the primary or secondary diagnosis was either neonatal withdrawal
6 May 2009 : Column 203W
symptoms from maternal use of drugs of addiction or withdrawal from therapeutic use of drugs in newborns. It is not possible to provide information on the type of drug to which a newborn child is addicted.

Counts of FCEs with a primary or secondary diagnosis of neonatal withdrawal symptoms from maternal use of drugs by strategic health authority (SHA) of residence for the period 2006-07 and 2007-08
SHA of residence	Total finished consultant birth episodes
	2006-07	2007-08
North East SHA	52	9
North West SHA	100	145
Yorkshire and the Humber SHA	163	122
East Midlands SHA	64	51
West Midlands SHA	82	56
East of England SHA	95	66
London SHA	66	51
South East Coast SHA	40	30
South Central SHA	20	42
South West SHA	60	81
Other and unknown	469	577
Total	1,211	1,230

6 May 2009 : Column 204W

Counts of FCEs with a primary or secondary diagnosis of neonatal withdrawal symptoms from maternal use of drugs by SHA of residence for the period 2003-04 and 2005-06
SHA of residence	Total finished consultant birth episodes
	2005-06	2004-05	2003-04
Norfolk, Suffolk and Cambridge SHA	*	*	*
Bedfordshire and Hertfordshire SHA	12	16	10
Essex SHA	0	8	*
North West London SHA	11	11	11
North Central London SHA	12	13	*
North East London SHA	*	0	*
South East London SHA	*	*	*
South West London SHA	*	0	*
Northumberland, Tyne and Wear SHA	6	*	*
County Durham and Tees Valley SHA	17	30	40
North and East Yorkshire and Northern Lincolnshire SHA	23	27	45
West Yorkshire SHA	12	11	27
Cumbria and Lancashire SHA	7	12	16
Greater Manchester SHA	10	8	11
Cheshire and Merseyside SHA	54	63	40
Thames Valley SHA	7	*	*
Hampshire and Isle of Wight SHA	*	9	7
Kent and Medway SHA	0	*	*
Surrey and Sussex SHA	13	11	13
Avon, Gloucestershire and Wiltshire SHA	62	40	44
South West Peninsula SHA	17	17	10
Dorset and Somerset SHA	28	8	9
South Yorkshire SHA	*	*	*
Trent SHA	6	8	10
Leicestershire, Northamptonshire and Rutland SHA	21	*	0
Shropshire and Staffordshire SHA	13	6	12
Birmingham and the Black Country SHA	*	*	*
West Midlands South SHA	*	0	6
Other and unknown	860	873	817
Total	1,211	1,193	1,156
Notes: 1. ICD-10 diagnosis codes used: P96.1 Neonatal withdrawal symptoms from maternal use of drugs of addiction. P96.2 Withdrawal symptoms form therapeutic use of drugs in newborn. 2. Low numbers: Due to reasons of confidentiality, figures between one and five have been suppressed and replaced with ‘*’ (an asterisk). 3. Ungrossed data: Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed). Source: Hospital Episode Statistics, The Information Centre for health and social care

Drugs: Misuse

Mr. Lansley: To ask the Secretary of State for Health how many people were admitted to hospital for conditions related to the misuse of illegal drugs (a) in each region in each year since 1997-98 and (b) in each primary care trust area in the last year for which figures are available. [272787]

Dawn Primarolo: This information is not collected centrally.

Eating Disorders

Norman Lamb: To ask the Secretary of State for Health how many (a) males and (b) females aged (i) under 10, (ii) between 10 and 18 and (iii) over 18 years in each region were admitted to hospital for eating disorders in each of the last five years. [272856]

Phil Hope: The information requested has been placed in the Library.

Epilepsy: Health Services

Mr. Sanders: To ask the Secretary of State for Health what recent guidance his Department has issued to (a) local authorities, (b) educational institutions and (c) voluntary organisations on the provision of services to those with epilepsy. [270407]

Ann Keen: The Department has issued no recent guidance to local authorities, educational institutions and voluntary organisations on the provision of services specifically for those living with epilepsy.

6 May 2009 : Column 205W

However, officials have been working with NHS Choices to produce detailed guidance and information for health professionals and the general public on epilepsy which can be accessed at the website

www.nhs.uk/livewell/epilepsy/Pages/Epilepsyhome.aspx

This guidance includes information on diagnosis and the available treatment options, specific information for children with epilepsy including those with learning disabilities and special education needs, as well as advice and links to sites covering issues around work and benefit rights.

---